市場調査レポート
商品コード
1309751

遺伝子検査の世界市場:用途別、技術別、製品別、ユーザー別予測 - エグゼクティブコンサルタントガイド付き(2023年~2027年)

Genetic Testing Markets. Global Market Analysis with Forecasts by Applications, Technologies, Products and Users. With Executive and Consultant Guides 2023 to 2027

出版日: | 発行: Howe Sound Research | ページ情報: 英文 534 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
遺伝子検査の世界市場:用途別、技術別、製品別、ユーザー別予測 - エグゼクティブコンサルタントガイド付き(2023年~2027年)
出版日: 2023年07月05日
発行: Howe Sound Research
ページ情報: 英文 534 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界の遺伝子検査市場について調査し、市場の概要とともに、用途別、技術別、製品別、ユーザー別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場ガイド

第2章 イントロダクションと市場の定義

第3章 市場概要

  • 市場参入組織
    • 学術研究機関
    • 診断試験開発者
    • 計装サプライヤー
    • 薬品・試薬メーカー
    • 病理サプライヤー
    • 独立系臨床検査室
    • 公共の国立/地域研究所
    • 病院検査室
    • 臨床検査室
    • 監査機関
    • 認証機関
  • 遺伝子検査- 種類、事例、考察
  • 産業構造

第4章 市場動向

  • 成長促進要因
  • 成長抑制要因
  • 計装、自動化、診断の動向

第5章 遺伝子検査の最近の展開

第6章 主要企業のプロファイル

  • 10x Genomics, Inc.
  • 23andME Inc.
  • Abbott Laboratories
  • Adaptive Biotechnologies
  • Admera Health, LLC
  • Agilent/Dako
  • Akonni Biosystems
  • Amoy Diagnostics Co., Ltd.
  • Ancestry.com LLC
  • Anchor Dx
  • Arc Bio
  • Arrayit Corporation
  • ARUP Laboratories
  • Aus Diagnostics
  • BaseClear
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocept, Inc.
  • Biodesix Inc.
  • BioFluidica
  • BioGenex
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • C2i Genomics
  • CareDx
  • Caris Molecular Diagnostics
  • CellMax Life
  • Centogene
  • Cepheid(Danaher)
  • Circulogene
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics, Inc.-A BGI Company
  • CosmosID
  • Dante Labs
  • Datar Cancer Genetics Limited
  • Diasorin S.p.A.
  • Element Biosciences
  • Element Biosciences
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific
  • Excellerate Bioscience
  • Fabric Genomics
  • Freenome
  • Fujirebio
  • Fulgent Genetics
  • Gene by Gene, Ltd.
  • Genedrive
  • GeneFirst Ltd.
  • Genetron Holdings
  • Genomics England
  • Genomics Personalized Health(GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grifols
  • Guardant Health
  • Guardiome
  • HeiScreen
  • Helix
  • Helix OpCo
  • Helomics
  • Hologic
  • HTG Molecular Diagnostics
  • Human Longevity, Inc.
  • iCellate
  • Illumina
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation
  • Invivoscribe
  • Karius
  • Letsgetchecked
  • Lunglife AI Inc
  • Macrogen
  • MDNA Life SCIENCES, Inc.
  • MDx Health
  • Medgenome
  • Menarini Silicon Biosystems
  • Meridian Bioscience
  • Mesa Biotech(Thermo Fisher)
  • Mesa Laboratories, Inc.
  • Metabiomics Corp
  • miR Scientific
  • MNG Labs
  • NantHealth, Inc.
  • Natera
  • Nebula Genomics
  • NeoGenomics
  • New England Biolabs, Inc.
  • NGeneBio
  • Novogene Bioinformatics Technology Co., Ltd.
  • Omega Bioservices
  • Oncocyte
  • OncoDNA
  • OpGen
  • ORIG3N, Inc.
  • Origene Technologies
  • Oxford Nanopore Technologies
  • Pacific Biosciences
  • Panagene
  • PathoQuest S.A.
  • Perkin Elmer(now Revvity)
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega
  • Protagen Diagnostics
  • Qiagen
  • QuantuMDx
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies
  • Seegene
  • Sema4 Holdings
  • Sequencing.com
  • Siemens Healthineers
  • simfo GmbH
  • Singlera Genomics Inc.
  • Singular Genomics
  • SkylineDx
  • Standard BioTools
  • Sure Genomics, Inc.
  • Sysmex
  • Sysmex Inostics
  • Tempus Labs, Inc.
  • Thermo Fisher Scientific Inc.
  • Ultima Genomics
  • Ultima Genomics
  • Variantyx
  • Vela Diagnostics
  • Volition
  • Vyant Bio
  • Zymo Research Corp

第7章 世界市場規模

  • 世界市場、国別
  • 世界市場、用途別
  • 世界市場、技術別
  • 世界市場、製品別
  • 世界市場、ユーザー別

第8章 市場規模、用途別

  • 新生児検査
  • NIPT
  • 予測テスト
  • 腫瘍学検査
  • DTCテスト市場
  • その他

第9章 世界の遺伝子検査市場、技術別

  • PCR検査
  • NGS
  • 細胞遺伝学的検査
  • その他

第10章 世界の遺伝子検査市場、製品別

  • 装置
  • 試薬およびキット
  • ソフトウェア
  • サービス

第11章 世界の遺伝子検査市場、ユーザー別

  • 学術
  • 臨床
  • 医薬品
  • 工業用およびその他

第12章 遺伝子検査の未来

第13章 付録

図表

Table of Tables

  • Table 1 Most Common Traditional Genetic Disorders
  • Table 2 The Base Pairs
  • Table 3 Market Players by Type
  • Table 4 The Different Types of Genetic Tests
  • Table 5 Five Factors Driving Growth
  • Table 6 Four Factors Limiting Growth
  • Table 7 Seven Key Diagnostic Laboratory Technology Trends
  • Table 8 Global Market by Country
  • Table 9 Global Market by Application
  • Table 10 Global Market by Technology
  • Table 11 Global Market by Product
  • Table 12 Global Market by User
  • Table 13 Newborn Segment by Country
  • Table 14 NIPT Segment by Country
  • Table 15 Predictive Segment by Country
  • Table 16 Oncology Segment by Country
  • Table 17 DTC Segment by Country
  • Table 18 Other Segment by Country
  • Table 19 PCR Segment by Country
  • Table 20 NGS Segment by Country
  • Table 21 Cytogenetic Segment by Country
  • Table 22 Other Segment by Country
  • Table 23 Instruments Segment by Country
  • Table 24 Reagents and Kits Segment by Country
  • Table 25 Software Segment by Country
  • Table 26 Services Segment by Country
  • Table 27 Academic Segment by Country
  • Table 28 Clinical Segment by Country
  • Table 29 Pharmaceutical Segment by Country
  • Table 30 Industrial and Other Segment by Country
  • Table 31 Clinical Lab Fee Schedule
  • Table 32 The Most Common Assays
  • Table 33 Largest Revenue Assays

Table of Figures

  • Figure 1 Global Health Care Spending
  • Figure 2 The Lab Test Pie
  • Figure 3 DNA Strands and Chromosomes
  • Figure 4 Karyogram of Human Chromosomes
  • Figure 5 Size of Various Genomes
  • Figure 6 The Road to Diagnostics
  • Figure 7 The Changing Age of the World Population
  • Figure 8 Health Care Consumption by Age
  • Figure 9 Cancer Incidence - Age at Diagnosis
  • Figure 10 Centralized vs. Decentralized Laboratory Service
  • Figure 11 A Highly Multiplexed Syndromic Testing Unit
  • Figure 12 The Real Cost to Sequence the Human Genome
  • Figure 13 The Codevelopment Process
  • Figure 14 Comparing MDx Diagnostic and Traditional Testing
  • Figure 15 Country Market Shares
  • Figure 16 Application Share by Year
  • Figure 17 Application Segment Growth Rates
  • Figure 18 Segment Share Shifts
  • Figure 19 Application Segment Share Base Year
  • Figure 20 Application Segment Share Final Year
  • Figure 21 Technology Share by Year
  • Figure 22 Technology Segment Growth Rates
  • Figure 23 Technology Segment Share Shifts
  • Figure 24 Technology Segment Share Base Year
  • Figure 25 Technology Segment Share Final Year
  • Figure 26 Product Share by Year
  • Figure 27 Product Segment Growth Rates
  • Figure 28 Product Segment Share Shifts
  • Figure 29 Product Segment Share Base Year
  • Figure 30 Product Segment Share Final Year
  • Figure 31 User Share by Year
  • Figure 32 User Segment Growth Rates
  • Figure 33 User Segment Share Shifts
  • Figure 34 User Segment Share Base Year
  • Figure 35 User Segment Share Final Year
  • Figure 36 Newborn vs. Total Market Growth
  • Figure 37 NIPT vs. Total Market Growth
  • Figure 38 Predictive vs. Total Market Growth
  • Figure 39 Oncology vs. Total Market Growth
  • Figure 40 DTC vs. Total Market Growth
  • Figure 41 Other vs. Total Market Growth
  • Figure 42 PCR vs. Total Market Growth
  • Figure 43 NGS vs. Total Market Growth
  • Figure 44 Cytogenetic vs. Total Market Growth
  • Figure 45 Other vs. Total Market Growth
  • Figure 46 Instrument vs. Total Market Growth
  • Figure 47 Reagents and Kits vs. Total Market Growth
  • Figure 48 Software vs. Total Market Growth
  • Figure 49 Services vs. Total Market Growth
  • Figure 50 Academic vs. Total Market Growth
  • Figure 51 Clinical vs. Total Market Growth
  • Figure 52 Pharmaceutical vs. Total Market Growth
  • Figure 53 Industrial and Other vs. Total Market Growth
目次

OVERVIEW:

Unlimited growth potential? Genetic Testing has crossed the chasm and is now growing in every area. What are the opportunities? What are the pitfalls?

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Genetic Testing - Strategic Situation Analysis
  • 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition

  • 2.1 Genetic Testing Definition in This Report
  • 2.2 The Genomics Revolution
  • 2.3 Market Definition
    • 2.3.1 Revenue Market Size.
    • 2.3.2 Newborn Screening
    • 2.3.3 Non Invasise Pregnancy Testing
    • 2.3.4 Predictive
    • 2.3.5 Oncology
    • 2.3.6 Direct to Consumer
    • 2.3.7 Other Application
    • 2.3.8 PCR
    • 2.3.9 NGS
    • 2.3.10 Cytogenetic
    • 2.3.11 Other Technology
  • 2.4 Methodology
    • 2.4.1 Methodology
    • 2.4.2 Sources
    • 2.4.3 Authors
  • 2.5 Perspective: Healthcare and the IVD Industry
    • 2.5.1 Global Healthcare Spending
    • 2.5.2 Spending on Diagnostics
    • 2.5.3 Important Role of Insurance for Diagnostics
  • 2.6 Chromosomes, Genes and Epigenetics
    • 2.6.1 Chromosomes
    • 2.6.2 Genes
    • 2.6.3 Epigenetics

3 Market Overview

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Diagnostic Test Developer
    • 3.1.3 Instrumentation Supplier
    • 3.1.4 Chemical/Reagent Supplier
    • 3.1.5 Pathology Supplier
    • 3.1.6 Independent Clinical Laboratory
    • 3.1.7 Public National/regional Laboratory
    • 3.1.8 Hospital Laboratory
    • 3.1.9 Physicians Office Lab (POLS)
    • 3.1.10 Audit Body
    • 3.1.11 Certification Body
  • 3.2 Genetic Tests -Types, Examples and Discussion
    • 3.2.1 Preimplantation Genetic Diagnosis- An Emerging Market
    • 3.2.2 Prenatal Diagnosis - New Technologies Create Opportunity
    • 3.2.3 Newborn Screening
    • 3.2.4 Diagnostic Testing
    • 3.2.5 Carrier Testing
    • 3.2.6 Predictive and Presymptomatic Testing
    • 3.2.7 Pharmacogenomics
    • 3.2.8 Forensic Testing
    • 3.2.9 Parental Testing
    • 3.2.10 Ancestral Testing
  • 3.3 Industry Structure
    • 3.3.1 Hospital's Testing Share
    • 3.3.2 Economies of Scale
    • 3.3.3 Hospital vs. Central Lab
    • 3.3.4 Physician Office Lab's
    • 3.3.5 Physician's and POCT

4 Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Genetic Discoveries Creating New Diagnostic Markets.
    • 4.1.2 The Aging Effect
    • 4.1.3 Pharmacogenomics Drives Further Growth.
    • 4.1.4 Oncology and Liquid Biopsy Enter New Era
    • 4.1.5 Fertility Practice Growth drives market
    • 4.1.6 Direct to Consumer begins to break out
  • 4.2 Factors Limiting Growth
    • 4.2.1 Increased Competition Lowers Price
    • 4.2.2 Lower Costs
    • 4.2.3 Testing usage analysis curtailing growth
    • 4.2.4 Wellness has a downside
  • 4.3 Instrumentation, Automation and Diagnostic Trends
    • 4.3.1 Traditional Automation and Centralization
    • 4.3.2 The New Automation, Decentralization and Point of Care
    • 4.3.3 Instruments Key to Market Share
    • 4.3.4 Bioinformatics Plays a Role
    • 4.3.5 PCR Takes Command
    • 4.3.6 Next Generation Sequencing Fuels a Revolution
    • 4.3.7 NGS Impact on Pricing
    • 4.3.8 Whole Genome Sequencing, A Brave New World
    • 4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10 Shifting Role of Diagnostics

5 Genetic Testing Recent Developments

  • 5.1 Recent Developments
    • 5.1.1 Importance of This Section
    • 5.1.2 How to Use This Section
  • 5.2 Novitas Rescinds Coverage for Multiple Genetic Tests
  • 5.3 PerkinElmer (now Revvity) Becomes Dx Life Science Firm
  • 5.4 New POC Genotyping Tests Based on Electromagnetic Detection
  • 5.5 GenoMe Dx Launching dPCR Cancer Test
  • 5.6 mDetect To Trial Breast Cancer Liquid Biopsy
  • 5.7 Genomics England, Aims to Sequence 100K Newborns
  • 5.8 Juno Diagnostics NIPT With At-Home Sample Collection
  • 5.9 Cardio Diagnostics Launches Genetic Cario Risk Test
  • 5.10 Universal Genetic Testing in Breast Cancer Further Supported
  • 5.11 Aniling Gets CE-IVD Marks for Cancer Sequencing Tests
  • 5.12 MyOme Lands Investment for WGS
  • 5.13 Type 2 Diabetes GWAS Enables Risk Prediction
  • 5.14 LetsGetChecked to Acquire Veritas Genetics
  • 5.15 Guardant Health Plans New Comprehensive Assay
  • 5.16 Tesis Labs Raises $20M
  • 5.17 Sema4: Sema4 Elements
  • 5.18 Clarified Precision Medicine Acquires Interpares Biomedicine
  • 5.19 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
  • 5.20 Illumina, Belgium Genetic Centers Partner on WGS-Based Dx
  • 5.21 NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology
  • 5.22 Progenity Revenues Fall on COVID-19 Effect
  • 5.23 Natera Launches Tumor Genomic Profiling Assay
  • 5.24 23andMe To Go Public
  • 5.25 Guardant Health to Offer Tumor Tissue Sequencing
  • 5.26 Ancestry Quits Health Offering
  • 5.27 DTC Firm MyDNA Merges With Gene by Gene
  • 5.28 Aetna Coverage for NIPT to Include All Pregnancies
  • 5.29 Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing
  • 5.30 Tumor, Germline Testing of Cancer Patients Can Give Discordant Results

6 Profiles of Key Companies

  • 6.1 10x Genomics, Inc.
  • 6.2 23andME Inc.
  • 6.3 Abbott Laboratories
  • 6.4 Adaptive Biotechnologies
  • 6.5 Admera Health, LLC
  • 6.6 Agilent/Dako
  • 6.7 Akonni Biosystems
  • 6.8 Amoy Diagnostics Co., Ltd.
  • 6.9 Ancestry.com LLC
  • 6.10 Anchor Dx
  • 6.11 Arc Bio
  • 6.12 Arrayit Corporation
  • 6.13 ARUP Laboratories
  • 6.14 Aus Diagnostics
  • 6.15 BaseClear
  • 6.16 Baylor Miraca Genetics Laboratories
  • 6.17 Beckman Coulter Diagnostics
  • 6.18 Becton, Dickinson and Company
  • 6.19 BGI Genomics Co. Ltd
  • 6.20 Bioarray Genetics
  • 6.21 Biocept, Inc.
  • 6.22 Biodesix Inc.
  • 6.23 BioFluidica
  • 6.24 BioGenex
  • 6.25 Biolidics Ltd
  • 6.26 bioMérieux Diagnostics
  • 6.27 Bioneer Corporation
  • 6.28 Bio-Rad Laboratories, Inc
  • 6.29 Bio-Techne
  • 6.30 C2i Genomics
  • 6.31 CareDx
  • 6.32 Caris Molecular Diagnostics
  • 6.33 CellMax Life
  • 6.34 Centogene
  • 6.35 Cepheid (Danaher)
  • 6.36 Circulogene
  • 6.37 Clinical Genomics
  • 6.38 Color Genomics
  • 6.39 Complete Genomics, Inc. - A BGI Company
  • 6.40 CosmosID
  • 6.41 Dante Labs
  • 6.42 Datar Cancer Genetics Limited
  • 6.43 Diasorin S.p.A.
  • 6.44 Element Biosciences
  • 6.45 Element Biosciences
  • 6.46 Epic Sciences
  • 6.47 Epigenomics AG
  • 6.48 Eurofins Scientific
  • 6.49 Excellerate Bioscience
  • 6.50 Fabric Genomics
  • 6.51 Freenome
  • 6.52 Fujirebio
  • 6.53 Fulgent Genetics
  • 6.54 Gene by Gene, Ltd.
  • 6.55 Genedrive
  • 6.56 GeneFirst Ltd.
  • 6.57 Genetron Holdings
  • 6.58 Genomics England
  • 6.59 Genomics Personalized Health (GPH)
  • 6.60 GenomOncology
  • 6.61 Genzyme Corporation
  • 6.62 Grifols
  • 6.63 Guardant Health
  • 6.64 Guardiome
  • 6.65 HeiScreen
  • 6.66 Helix
  • 6.67 Helix OpCo
  • 6.68 Helomics
  • 6.69 Hologic
  • 6.70 HTG Molecular Diagnostics
  • 6.71 Human Longevity, Inc.
  • 6.72 iCellate
  • 6.73 Illumina
  • 6.74 Incell Dx
  • 6.75 Inivata
  • 6.76 Integrated Diagnostics
  • 6.77 Invitae Corporation
  • 6.78 Invivoscribe
  • 6.79 Karius
  • 6.80 Letsgetchecked
  • 6.81 Lunglife AI Inc
  • 6.82 Macrogen
  • 6.83 MDNA Life SCIENCES, Inc.
  • 6.84 MDx Health
  • 6.85 Medgenome
  • 6.86 Menarini Silicon Biosystems
  • 6.87 Meridian Bioscience
  • 6.88 Mesa Biotech (Thermo Fisher)
  • 6.89 Mesa Laboratories, Inc.
  • 6.90 Metabiomics Corp
  • 6.91 miR Scientific
  • 6.92 MNG Labs
  • 6.93 NantHealth, Inc.
  • 6.94 Natera
  • 6.95 Nebula Genomics
  • 6.96 NeoGenomics
  • 6.97 New England Biolabs, Inc.
  • 6.98 NGeneBio
  • 6.99 Novogene Bioinformatics Technology Co., Ltd.
  • 6.100 Omega Bioservices
  • 6.101 Oncocyte
  • 6.102 OncoDNA
  • 6.103 OpGen
  • 6.104 ORIG3N, Inc.
  • 6.105 Origene Technologies
  • 6.106 Oxford Nanopore Technologies
  • 6.107 Pacific Biosciences
  • 6.108 Panagene
  • 6.109 PathoQuest S.A.
  • 6.110 Perkin Elmer (now Revvity)
  • 6.111 Personal Genome Diagnostics
  • 6.112 Personalis
  • 6.113 Precipio
  • 6.114 PrecisionMed
  • 6.115 Promega
  • 6.116 Protagen Diagnostics
  • 6.117 Qiagen
  • 6.118 QuantuMDx
  • 6.119 Roche Molecular Diagnostics
  • 6.120 Roswell Biotechnologies
  • 6.121 Seegene
  • 6.122 Sema4 Holdings
  • 6.123 Sequencing.com
  • 6.124 Siemens Healthineers
  • 6.125 simfo GmbH
  • 6.126 Singlera Genomics Inc.
  • 6.127 Singular Genomics
  • 6.128 SkylineDx
  • 6.129 Standard BioTools
  • 6.130 Sure Genomics, Inc.
  • 6.131 Sysmex
  • 6.132 Sysmex Inostics
  • 6.133 Tempus Labs, Inc.
  • 6.134 Thermo Fisher Scientific Inc.
  • 6.135 Ultima Genomics
  • 6.136 Ultima Genomics
  • 6.137 Variantyx
  • 6.138 Vela Diagnostics
  • 6.139 Volition
  • 6.140 Vyant Bio
  • 6.141 Zymo Research Corp

7 Global Market Size

  • 7.1 Global Market by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Country Market Shares
  • 7.2 Global Market by Application
    • 7.2.1 Table - Global Market by Application
    • 7.2.2 Chart - Application Share by Year
    • 7.2.3 Chart - Application Segment Growth Rates
    • 7.2.4 Chart - Application Segment Share Shifts
    • 7.2.5 Chart - Application Segment Share Base Year
    • 7.2.6 Chart - Application Segment Share Final Year
  • 7.3 Global Market by Technology
    • 7.3.1 Table - Global Market by Technology
    • 7.3.2 Chart - Technology Share by Year
    • 7.3.3 Chart - Technology Segment Growth Rates
    • 7.3.4 Chart - Technology Segment Share Shifts
    • 7.3.5 Chart - Technology Segment Share Base Year
    • 7.3.6 Chart - Technology Segment Share Final Year
  • 7.4 Global Market by Product
    • 7.4.1 Table - Global Market by Product
    • 7.4.2 Chart - Product Share by Year
    • 7.4.3 Chart - Product Segment Growth Rates
    • 7.4.4 Chart - Product Segment Share Shifts
    • 7.4.5 Chart - Product Segment Share Base Year
    • 7.4.6 Chart - Product Segment Share Final Year
  • 7.5 Global Market by User
    • 7.5.1 Table - Global Market by User
    • 7.5.2 Chart - User Share by Year
    • 7.5.3 Chart - User Segment Growth Rates
    • 7.5.4 Chart - User Segment Share Shifts
    • 7.5.5 Chart - User Segment Share Base Year
    • 7.5.6 Chart - User Segment Share Final Year

8 Market Sizes by Application

  • 8.1 Newborn Testing Market
    • 8.1.1 Table Newborn - by Country
    • 8.1.2 Chart - Newborn Growth
  • 8.2 NIPT Market
    • 8.2.1 Table NIPT - by Country
    • 8.2.2 Chart - NIPT Growth
  • 8.3 Predictive Testing Market
    • 8.3.1 Table Predictive - by Country
    • 8.3.2 Chart - Predictive Growth
  • 8.4 Oncology Testing Market
    • 8.4.1 Table Oncology - by Country
    • 8.4.2 Chart - Oncology Growth
  • 8.5 DTC Testing Market
    • 8.5.1 Table DTC - by Country
    • 8.5.2 Chart - DTC Growth
  • 8.6 Other Testing Market
    • 8.6.1 Table Other - by Country
    • 8.6.2 Chart - Other Growth

9 Global Genetic Testing Market by Technology

  • 9.1 PCR Testing Market
    • 9.1.1 Table PCR - by Country
    • 9.1.2 Chart - PCR Growth
  • 9.2 NGS Market
    • 9.2.1 Table NGS - by Country
    • 9.2.2 Chart - NGS Growth
  • 9.3 Cytogenetic Testing Market
    • 9.3.1 Table Cytogenetic - by Country
    • 9.3.2 Cytogenetic - Predictive Growth
  • 9.4 Other Testing Market
    • 9.4.1 Table Other - by Country
    • 9.4.2 Chart - Other Growth

10 Global Genetic Testing Market by Product

  • 10.1 Instruments Market
    • 10.1.1 Table Instruments - by Country
    • 10.1.2 Chart - Instrument Growth
  • 10.2 Reagents and Kits Market
    • 10.2.1 Table Reagents and Kits - by Country
    • 10.2.2 Chart - Reagents and Kits Growth
  • 10.3 Software Market
    • 10.3.1 Table Software - by Country
    • 10.3.2 Software Growth
  • 10.4 Services Market
    • 10.4.1 Table Services - by Country
    • 10.4.2 Chart - Services Growth

11 Global Genetic Testing Market by User

  • 11.1 Academic Market
    • 11.1.1 Table Academic - by Country
    • 11.1.2 Chart - Academic Growth
  • 11.2 Clinical Market
    • 11.2.1 Table Clinical - by Country
    • 11.2.2 Chart - Clinical Growth
  • 11.3 Pharmaceutical Market
    • 11.3.1 Table Pharmaceutical - by Country
    • 11.3.2 Pharmaceutical - Predictive Growth
  • 11.4 Industrial and Other Market
    • 11.4.1 Table Industrial and Other - by Country
    • 11.4.2 Chart - Industrial and Other Growth

12 The Future of Genetic Testing

13 Appendices

  • 13.1 United States Medicare System: Laboratory Fees Schedule
  • 13.2 The Most Used IVD Assays
  • 13.3 The Highest Grossing Assays